NCT00002461
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
- Locations
-
- Albert Einstein Comprehensive Cancer Center The Bronx, New York, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,062 public trials
2,038 recruiting studies
Lymphoproliferative Disorders trial results
NCT00221039
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Rush-Presbyterian Hospital Chicago, Illinois, United States
- Boston Medical Center Boston, Massachusetts, United States
- University of Minnesota Minneapolis, Minnesota, United States
- University Hospital of Cleveland/Case Western Reserve University Cleveland, Ohio, United States
Completed
α-TEA in Advanced Cancer
NCT02192346
- Conditions
- Carcinoma, Hemic and Lymphatic Diseases, Immune System Diseases, +16 more
- Locations
-
- Providence Oncology & Hematology Care Clinic- Southeast Clackamas, Oregon, United States
- Providence Oncology & Hematoloty Care Clinic- Newberg Newberg, Oregon, United States
- Providence Oncology & Hematology Care Clinic- Willamette Falls Oregon City, Oregon, United States
- Providence Oncology & Hematology Care Clinic- Eastside Portland, Oregon, United States
Completed
Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma
NCT00255801
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- Hackensack University Medical Center Cancer Center Hackensack, New Jersey, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
- NYU Cancer Institute at New York University Medical Center New York, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT00482378
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT00777114
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- University of Michigan Ann Arbor, Michigan, United States
- Weill Cornell Medical College New York, United States
NCT00002865
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Comprehensive Cancer Center of Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States
NCT01852799
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Shanghai Changzheng Hospital Shanghai, Shanghai Municipality, China
NCT00295841
- Conditions
- Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +20 more
- Locations
-
- Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States
NCT01294579
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Novartis Investigative Site Chandler, Arizona, United States
- Novartis Investigative Site Burbank, California, United States
- Novartis Investigative Site Fresno, California, United States
- Novartis Investigative Site Oxnard, California, United States